Cibc World Market Inc. Guardant Health, Inc. Transaction History

Cibc World Market Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$21.58 - $29.5 $14,178 - $19,381	657 Added 7.78%	9,106 $246,000
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $13,132 - $20,344	509 Added 6.41%	8,449 $250,000
Q2 2023 Aug 11, 2023	BUY	$20.94 - $38.01 $166,263 - $301,799	7,940 New	7,940 $284,000
Q4 2022 Feb 13, 2023	BUY	$25.44 - $59.78 $367,455 - $863,462	14,444 New	14,444 $393,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.